PlainRecalls

Ajanta Pharma Ltd.

Compiled from official public sources by the publisher.

3 recalls on record · Latest: May 13, 2026

Subscribe to new Ajanta Pharma Ltd. recalls (RSS)

Agency notice ledger

Federal filing book Ajanta Pharma Ltd. LIGHT-BOOK · SINGLE-AGENCY

#3,314 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,314 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 1 category
  • LATEST May 13, 2026
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Ajanta Pharma Ltd. accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Ajanta Pharma Ltd. sits among 14,151 recalling firms

Ajanta Pharma Ltd. ranks 3,314th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Ajanta Pharma Ltd. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3314th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Ajanta Pharma Ltd. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Ajanta Pharma Ltd. holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate May 13, 2026

Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03, c) 1000 Capsules, NDC 27241-098-10, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India
FDA Drug Moderate May 13, 2026

Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06.
FDA Drug Moderate May 13, 2026

Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-099-03

Ajanta Pharma Ltd. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Allegiant Health 3

Frequently Asked Questions

How many federal recall notices name Ajanta Pharma Ltd.? ▼
PlainRecalls indexes 3 distinct federal recall events naming Ajanta Pharma Ltd., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Ajanta Pharma Ltd. sit among other recalling firms? ▼
Ajanta Pharma Ltd. ranks #3,314 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Ajanta Pharma Ltd.'s notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Ajanta Pharma Ltd.'s filing book? ▼
Filings for Ajanta Pharma Ltd. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Ajanta Pharma Ltd.: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Ajanta Pharma Ltd.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026